Guggenheim Capital LLC Sells 2,891 Shares of The Beauty Health Company (NASDAQ:SKIN)

Guggenheim Capital LLC decreased its position in The Beauty Health Company (NASDAQ:SKIN – Get Rating) by 7.0% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 38,451 shares of the company’s stock after selling 2,891 shares during the period. Guggenheim Capital LLC’s holdings in Beauty Health were worth $453,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of the stock. MetLife Investment Management LLC lifted its holdings in Beauty Health by 3.1% during the third quarter. MetLife Investment Management LLC now owns 53,638 shares of the company’s stock worth $632,000 after acquiring an additional 1,596 shares in the last quarter. Nisa Investment Advisors LLC increased its position in shares of Beauty Health by 88.9% in the third quarter. Nisa Investment Advisors LLC now owns 4,490 shares of the company’s stock valued at $52,000 after acquiring an additional 2,113 shares during the last quarter. Axiom Investors LLC DE increased its position in Beauty Health by 1.4% during the third quarter. Axiom Investors LLC DE now owns 163,572 shares of the company’s stock worth $1,929,000 after buying an additional 2,205 shares during the last quarter. Jennison Associates LLC increased its position in Beauty Health by 8.0% during the third quarter. Jennison Associates LLC now owns 37,151 shares of the company’s stock worth $438,000 after buying an additional 2,754 shares during the last quarter. Finally, New York State Common Retirement Fund increased its position in Beauty Health by 2.1% during the third quarter. New York State Common Retirement Fund now owns 143,224 shares of the company’s stock worth $1,689,000 after buying an additional 2,894 shares during the last quarter. 78.37% of the stock is owned by institutional investors and hedge funds.

Beauty Health Price Performance

SKIN stock opened at $11.16 on Friday. The Beauty Health Company has a 12-month low of $8.25 and a 12-month high of $19.38. The company has a current ratio of 10.79, a quick ratio of 9.20 and a debt-to-equity ratio of 4.28. The firm’s 50-day moving average price is $11.43 and its two-hundred day moving average price is $11.18. The stock has a market capitalization of $1.48 billion, a price-to-earnings ratio of -62.00 and a beta of 1.16.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on the company. Piper Sandler lowered their price target on Beauty Health from $16.00 to $15.00 in a research report on Friday, December 16th. DA Davidson boosted their price target on Beauty Health from $32.00 to $35.00 and gave the company a “buy” rating in a research note on Wednesday, March 1st. Benchmark reiterated a “buy” rating and issued a $23.00 price target on shares of Beauty Health in a research note on Tuesday, February 28th. The Goldman Sachs Group lowered their price objective on shares of Beauty Health from $22.00 to $19.00 and set a “buy” rating for the company in a research report on Wednesday, November 23rd. Finally, Cowen lowered their price target on shares of Beauty Health from $20.00 to $15.00 and set an “outperform” rating for the company in a report on Thursday, February 16th. One equities research analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat.com, Beauty Health has an average rating of “Moderate Buy” and an average price target of $19.75.

Beauty Health Company Profile

(Get Rating)

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, peel, exfoliate, extract, infuse, and hydrate the skin with proprietary solutions and serums.